Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Genetic and environmental factors that regulate cytosolic epoxide hydrolase activity in normal human lymphocytes.
K K Norris, … , T M DeAngelo, E S Vesell
K K Norris, … , T M DeAngelo, E S Vesell
Published December 1, 1989
Citation Information: J Clin Invest. 1989;84(6):1749-1756. https://doi.org/10.1172/JCI114358.
View: Text | PDF
Research Article

Genetic and environmental factors that regulate cytosolic epoxide hydrolase activity in normal human lymphocytes.

  • Text
  • PDF
Abstract

To determine whether genetic mechanisms control large variations in cytosolic epoxide hydrolase (cEH) activity of unstimulated lymphocytes from normal human subjects, cEH activity was measured in (a) 6 sets of monozygotic (MZ) twins and 6 sets of dizygotic (DZ) twins; (b) 100 unrelated male subjects; and (c) 6 families. The twin study revealed predominantly genetic control (H2(1) = 0.95). Variability was markedly less within MZ (intrapair variance = 0.25) than DZ twins (intrapair variance = 6.33). In 100 unrelated male subjects the extent of interindividual variation was 11-fold. Unimodal distribution of values among 99 subjects encompassed a sixfold range. One outlier with very high activity clearly stood apart. Using the whole distribution curve we phenotyped members of six families. In the outlier's family, analysis of three generations suggested autosomal dominant transmission of high cEH activity. Analysis of the other 5 families and of 12 sets of twins, all from the large unimodal distribution, was consistent with either monogenic or polygenic control of variations within this mode. Several temporal host factors, including fever, the menstrual cycle, a 24-h fast, and diurnal variations, were investigated. Fever and fasting elevated cEH activity. Diurnal variations produced no observable alteration. During the menstrual cycle irregular fluctuations occurred.

Authors

K K Norris, T M DeAngelo, E S Vesell

×

Total citations by year

Year: 2014 2012 2010 2009 2005 2004 2003 2001 2000 1999 1995 1993 1992 1991 Total
Citations: 2 1 1 1 1 1 1 1 2 2 1 2 1 1 18
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (18)

Title and authors Publication Year
Design and discovery of soluble epoxide hydrolase inhibitors for the treatment of cardiovascular diseases
T Duflot, C Roche, F Lamoureux, D Guerrot, J Bellien
Expert Opinion on Drug Discovery 2014
The genetics of vascular incidents associated with second-generation antipsychotic administration
E Cocchi, A Drago, D Ronchi, A Serretti
Expert Review of Clinical Pharmacology 2014
Pharmacogenetics and Individualized Therapy: Maitland-van der Zee/Pharmacogenetics
B Sobrino, A Carracedo
Pharmacogenetics and Individualized Therapy: Maitland-van der Zee/Pharmacogenetics 2012
Effect of cytochrome P450 polymorphism on arachidonic acid metabolism and their impact on cardiovascular diseases
BN Zordoky, AO El-Kadi
Pharmacology & Therapeutics 2010
Soluble Epoxide Hydrolase Inhibition: Targeting Multiple Mechanisms of Ischemic Brain Injury with a Single Agent
JJ Iliff, NJ Alkayed
Future Neurology 2009
In vitro studies of the influence of glutathione transferases and epoxide hydrolase on the detoxification of acrylamide and glycidamide in blood
B Paulsson, A Rannug, AP Henderson, BT Golding, M Törnqvist, M Warholm
Mutation Research/Genetic Toxicology and Environmental Mutagenesis 2005
Vascular localization of soluble epoxide hydrolase in the human kidney
Z Yu, BB Davis, C Morisseau, BD Hammock, JL Olson, DL Kroetz, RH Weiss
American journal of physiology. Renal physiology 2004
Polymorphisms in Human Soluble Epoxide Hydrolase
BD Przybyla-Zawislak, PK Srivastava, J Vázquez-Matías, HW Mohrenweiser, JE Maxwell, BD Hammock, JA Bradbury, AE Enayetallah, DC Zeldin, DF Grant
Molecular pharmacology 2003
Cancer and Pregnancy
ER Barnea, E Jauniaux, PE Schwartz
2001
Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids
Z Yu, F Xu, LM Huse, C Morisseau, AJ Draper, JW Newman, C Parker, L Graham, MM Engler, BD Hammock, DC Zeldin, DL Kroetz
Circulation research 2000
Identification and Functional Characterization of Human Soluble Epoxide Hydrolase Genetic Polymorphisms
M Sandberg, C Hassett, ET Adman, J Meijer, CJ Omiecinski
The Journal of biological chemistry 2000
Epoxide hydrolase activity in human blood mononuclear leukocytes: individual differences in native and mitogen-stimulated cells
S Bernardini, H Norppa, E Elovaara
Mutation Research/Genetic Toxicology and Environmental Mutagenesis 1999
Handbook of Drug Metabolism
S Vee, W Day
Handbook of Drug Metabolism: Mechanisms and Implications 1999
Molecular basis of polymorphic drug metabolism
AK Daly
Journal of Molecular Medicine 1995
Metabolic polymorphisms
AK Daly, S Cholerton, W Gregory, JR Idle
Pharmacology & Therapeutics 1993
Some substrates and inhibitors of cytosolic epoxide hydrolase induce sister-chromatid exchanges in mammalian cells, but do not induce gene mutations in Salmonella typhimurium and V79 cells
A Krämer, J Pudil, H Frank, F Oesch, H Glatt
Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 1993
Biologic Rhythms in Clinical and Laboratory Medicine
Y Touitou, E Haus
1992
Genetic and environmental factors causing variation in drug response
ES Vesell
Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 1991

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts